+44 1478 350008Pancreatic Disorders & Therapy : Citations & Metrics Report
Articles published in Pancreatic Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Pancreatic Disorders & Therapy has got h-index 11, which means every article in Pancreatic Disorders & Therapy has got 11 average citations.
Following are the list of articles that have cited the articles published in Pancreatic Disorders & Therapy.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
40 | 50 | 25 | 28 | 9 | 1 | 7 | 11 | 21 | 35 | 20 | 33 | 30 | 5 |
Research, Review articles and Editorials |
1 | 0 | 2 | 3 | 7 | 1 | 5 | 5 | 16 | 17 | 17 | 25 | 26 | 5 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
39 | 50 | 18 | 14 | 2 | 0 | 2 | 6 | 5 | 6 | 3 | 2 | 4 | 0 |
Conference proceedings |
0 | 9 | 8 | 0 | 0 | 0 | 21 | 74 | 53 | 0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
19 | 42 | 46 | 48 | 62 | 45 | 39 | 55 | 73 | 39 | 31 | 6 | 0 | 0 |
| Journal total citations count | 437 |
| Journal impact factor | 1.58 |
| Journal 5 years impact factor | 3.08 |
| Journal cite score | 3.74 |
| Journal h-index | 11 |
| Journal h-index since 2019 | 9 |
Important citations (368)
elabbasy f, gadde r, hanna mm, sleeman d, livingstone a, etal. (2015) minimally invasive spleen-preserving distal pancreatectomy: does splenic vessel preservation have better postoperative outcomes? a systematic review and meta-analysis. hepatobiliary & pancreatic diseases international 14: 346-353. |
|
partelli s, cirocchi r, randolph j, parisi a, coratti a, etal. (2016) a systematic review and meta-analysis of spleen-preserving distal pancreatectomy with preservation or ligation of the splenic artery and vein. the surgeon 14: 109-118. |
|
rck rajendran s, ecc ejike c, gong m, hannah w, c udenigwe c (2017) preclinical evidence on the anticancer properties of food peptides. protein and peptide letters 24: 126-136. |
|
wu x, wu g, wu z, yao x, li g (2015) mir-200a suppresses the proliferation and metastasis in pancreatic ductal adenocarcinoma through downregulation of dek gene. translational oncology 9: 25-31. |
|
romney e, nagaraj vj (2015) in vitro model systems to investigate drug resistance mechanisms in pancreatic cancer cells. advances in biological chemistry 5: 286. |
|
grant tj, hua k, singh a (2016) chapter six-molecular pathogenesis of pancreatic cancer. progress in molecular biology and translational science 144: 241-275. |
|
ma j, zeng f, ma c, pang h, fang b, et al. (2016) synergistic reversal effect of epithelial-to-mesenchymal transition by mir-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells. american journal of cancer research 6: 1384. |
|
li z, guo j, xie k, zheng s (2015) vitamin d receptor signaling and pancreatic cancer cell emt. current pharmaceutical design 21: 1262-1267. |
|
sureban sm, qu d, houchen cw (2015) regulation of mirnas by agents targeting the tumor stem cell markers dclk1, msi1, lgr5, and bmi1. current pharmacology reports 1: 217-222. |
|
schiavone m, rampazzo e, casari a, battilana g, persano l, et al. (2014) zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer. disease models & mechanisms 7: 883-894. |
|
qu d, johnson j, chandrakesan p, weygant n, may r, aiello n, et al. (2017) doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. plos one 10: e0118933. |
|
rck rajendran s, ecc ejike c, gong m, hannah w, c udenigwe c (2017) preclinical evidence on the anticancer properties of food peptides. protein and peptide letters 24: 126-136. |
|
wu x, wu g, wu z, yao x, li g (2016) mir-200a suppresses the proliferation and metastasis in pancreatic ductal adenocarcinoma through downregulation of dek gene. translational oncology 9: 25-31. |
|
romney e, nagaraj vj (2015) in vitro model systems to investigate drug resistance mechanisms in pancreatic cancer cells. advances in biological chemistry 5: 286. |
|
grant tj, hua k, singh a (2016) chapter six-molecular pathogenesis of pancreatic cancer. progress in molecular biology and translational science 144: 241-275. |
|
ma j, zeng f, ma c, pang h, fang b, et al. (2016) synergistic reversal effect of epithelial-to-mesenchymal transition by mir-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells. american journal of cancer research 6: 1384. |
|
li z, guo j, xie k, zheng s (2015) vitamin d receptor signaling and pancreatic cancer cell emt. current pharmaceutical design 21: 1262-1267. |
|
sureban sm, qu d, houchen cw (2015) regulation of mirnas by agents targeting the tumor stem cell markers dclk1, msi1, lgr5, and bmi1. current pharmacology reports 1: 217-222. |
|
schiavone m, rampazzo e, casari a, battilana g, persano l, et al. (2014) zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer. disease models & mechanisms 7: 883-894. |
|
qu d, johnson j, chandrakesan p, weygant n, may r, et al. (2015) doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. plos one 10: e0118933. |
|